Prospective comparison of outcomes with azacitidine and decitabine in patients with AML ineligible for intensive chemotherapy

Author:

Zeidan Amer M.12,Fenaux Pierre3,Gobbi Marco4ORCID,Mayer Jiří5,Roboz Gail J.67ORCID,Krauter Jürgen8,Robak Tadeusz9ORCID,Kantarjian Hagop M.10,Novák Jan11,Jedrzejczak Wieslaw W.12ORCID,Thomas Xavier13,Ojeda-Uribe Mario14,Miyazaki Yasushi15,Min Yoo Hong16,Yeh Su-Peng17,Brandwein Joseph M.18ORCID,Gercheva Liana19,Demeter Judit20ORCID,Griffiths Elizabeth A.21ORCID,Yee Karen W. L.22ORCID,Issa Jean-Pierre J.23,Bewersdorf Jan Philipp1224,Keer Harold25,Hao Yong25,Azab Mohammad25,Döhner Hartmut26ORCID

Affiliation:

1. 1Section of Hematology, Department of Medicine, Yale University, New Haven, CT;

2. 2Yale Cancer Center, New Haven, CT;

3. 3Hôpital Saint Louis, Paris, France;

4. 4Ospedale Policlinico San Martino, Genova, Italy;

5. 5Fakultní Nemocnice, Brno, Czech Republic;

6. 6Division of Hematology and Medical Oncology, Weill Cornell Medicine, Cornell University, New York, NY;

7. 7NewYork-Presbyterian Hospital, New York, NY;

8. 8Städtisches Klinikum Braunschweig, Braunschweig, Germany;

9. 9Copernicus Memorial Hospital, Lodz, Poland; Department of Hematology, Medical University of Lodz, Lodz, Poland;

10. 10MD Anderson Cancer Center, University of Texas, Houston, TX;

11. 11Fakultní Nemocnice Královské Vinohrady, Praha, Czech Republic;

12. 12Uniwersyteckie Centrum Kliniczne, Warszawskiego Uniwersytetu Medycznego, Warsaw, Poland;

13. 13Centre Hospitalier Lyon Sud, Pierre-Bénite, France;

14. 14Groupe Hospitalier de la Région Mulhouse Sud-Alsace, Mulhouse, France;

15. 15Nagasaki University Hospital, Nagasaki, Japan;

16. 16Severance Hospital, Yonsei University Health System, Seoul, Republic of Korea;

17. 17China Medical University Hospital, Taichung, Taiwan, Republic of China;

18. 18University of Alberta Hospital, Edmonton, Canada;

19. 19Multiprofile Hospital for Active Treatment Sveta Marina EAD, Varna, Bulgaria;

20. 20Semmelweis Egyetem, Budapest, Hungary;

21. 21Roswell Park Cancer Institute, Buffalo, NY;

22. 22Princess Margaret Cancer Centre, Toronto, Canada;

23. 23Coriell Institute for Medical Research, Camden, NJ;

24. 24Leukemia Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY;

25. 25Astex Pharmaceuticals, Inc., Pleasanton, CA; and

26. 26Ulm University Hospital, Ulm, Germany

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3